Numerous people were accused of being werewolves and executed in Europe in the 15th, 16th, and 17th centuries. Some of them ...
Identify DCT growth opportunities through market segmentation, competitive rankings, technology trends, strategic alliances, M&A, venture funding and ESG insights.Dublin, Oct. 09, 2026 (GLOBE NEWSWIRE ...
Exelixis' (EXEL) clinical trials evaluating Zanzalintinib in various types of cancer are highly likely to succeed, RBC Capital Markets analysts said in a Friday note. Analysts sai ...
Novartis’ experimental del-desiran for a rare type of muscular dystrophy was expected to be a winner, with the Swiss company's CEO predicting annual peak sales of $5 billion. When a late-stage trial ...
VivoSim is a San Diego biotech company whose goal is to limit the impact of failure in human trials. By using lab-grown human ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results